Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

The Thyroid Gland

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcomes of deprescribing for people with life-limiting conditions: A systematic review.

Palliative medicine·2026

Same author

The conceptualisation and measurement of social frailty in older people: an umbrella review.

The Journal of frailty & aging·2025

Same author

Organising general practice for care homes: a multi-method study.

Health and social care delivery research·2025

Same author

Ecological study of the association between the English national vaccination programme and area deprivation inequalities in COVID-19 mortality.

BMJ open·2025

Same author

Which unmet social care needs have the biggest impact on healthy ageing? An analysis of data from the English Longitudinal Study of Ageing.

BMJ open·2025

Same author

Clinical validation of an artificial intelligence-based decision support system for diagnosis and risk stratification of heart failure (STRATIFYHF): a protocol for a prospective, multicentre longitudinal study.

BMJ open·2025

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Analytical aspects of thyroid antibodies estimation.

David Sinclair¹

¹Department of Clinical Biochemistry, Queen Alexandra Hospital, Portsmouth, UK. david.sinclair@porthosp.nhs.uk

|January 8, 2008

Summary

Detecting antibodies for autoimmune thyroid diseases like Graves

Area of Science:

Endocrinology and Immunology
Autoimmune disease research
Thyroid disease diagnostics

Background:

Autoimmune thyroid diseases (ATDs) pose diagnostic challenges due to difficulties in reliably detecting and monitoring specific antibodies.
Key antigens involved include thyroglobulin (TG), thyroid peroxidase (TPO), and the TSH receptor (TSHR), each with distinct antibody profiles.
The development of humoral responses to these antigens is influenced by genetic and environmental factors, including HLA linkage.

Purpose of the Study:

To review the antigens implicated in ATDs, the development of humoral responses, and the technical challenges in antibody detection and quantification.
To discuss the evolution of diagnostic assays for ATD antibodies, from older methods to modern immunoassays.
To highlight the complexities and limitations in current antibody testing methodologies for ATDs.

More Related Videos

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Related Experiment Videos

Last Updated: Jul 8, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Main Methods:

Review of scientific literature on autoimmune thyroid disease antigens and antibody detection methods.
Description of various immunoassay techniques, including immunofluorescence, passive tanned red cell agglutination, competitive and non-competitive immunoassays.
Discussion of bioassays and receptor assays for TSH receptor antibodies.

Main Results:

Multiple immunologically distinct configurations of thyroglobulin (TG) exist.
Thyroid peroxidase (TPO) is central to cell-mediated cytotoxicity, with multiple antibody-reactive epitopes.
TSH receptor (TSHR) antibodies can be stimulating or blocking, depending on the targeted subunit, and exhibit heterogeneity.
Assay sensitivity and specificity vary significantly due to the wide range of methods used in clinical laboratories.
Standardization of TPO antibody assays uses MRC 66/387, while TG antibody assays may use primary standard MRC 65/93.
Interference of TG antibodies in tumor marker assays for thyroid carcinoma necessitates simultaneous TG antibody estimation.
TSHR antibody testing faces challenges due to antibody heterogeneity and temporal changes within patients.

Conclusions:

Reliable diagnosis, prediction, and monitoring of ATDs are hampered by technical difficulties in antibody detection and quantification.
Advancements in immunoassays have improved sensitivity and specificity for TG and TPO antibodies, but standardization remains a challenge.
TSHR antibody assays require further development to accurately capture the heterogeneity and dynamic nature of these antibodies for improved diagnostic accuracy.